Trial · NCT07903324
Permethrin-Treated Baby Wraps for Malaria Prevention in Refugee Settings
NCT07903324, Not applicable, Not yet recruiting, University of North Carolina, Chapel Hill
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Permethrin-Treated Baby Wraps for Malaria Prevention in Refugee Settings. Trials, record NCT07903324. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07903324
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Permethrin-Treated Baby Wraps for Malaria Prevention in Refugee Settings
- NCT number
- NCT07903324
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 1,350 participants, estimated
- Lead sponsor
- University of North Carolina, Chapel Hill
- Conditions
- Malaria (Plasmodium Falciparum), Malaria Incidence
- Interventions
- Factory-treated lesu, Soaked lesu, Untreated lesu
- First posted
- 2026-10-29
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes35
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of clinical malaria in children | From enrollment to Month 6 | Acute febrile illness defined as fever (temperature ≥38.0 Celsius) or fever reported in past 24 hours AND positive malaria rapid diagnostic test (RDT), confirmed by light microscopy (performed later), at scheduled or unscheduled study clinic visit |
| Secondary | Incidence of hospitalizations due to malaria | From enrollment to Month 6 | Incidence of admissions from clinic after a positive malaria RDT |
| Secondary | Incidence of hospitalizations due to any cause | From enrollment to Month 6 | Incidence of admissions from clinic after a positive malaria RDT |
| Secondary | Number of deaths due to any cause | From enrollment to Month 6 | Incidence of admissions from clinic after a positive malaria RDT |
| Secondary | Number of deaths due to malaria | From enrollment to Month 6 | Incidence of admissions from clinic after a positive malaria RDT |
| Secondary | Incidence of non-malarial febrile episodes in children | From enrollment to Month 6 | Incidence of participants experiencing acute febrile illness and negative malaria RDT at a scheduled or unscheduled study visit. |
| Secondary | Wrap attrition | From enrollment to Month 6 | The number of wraps lost or damaged and requiring replacement. |
| Secondary | Off-target use of wraps | From enrollment to Month 6 | Self-reported use for other purposes or use with other household members |
| Secondary | Incidence of malaria among mothers or other children (age < 5) in the household | From enrollment to Month 6 | Acute febrile illness defined as fever (temperature ≥38.0 Celsius) or fever reported in past 24 hours AND positive malaria rapid diagnostic test (RDT) at scheduled or unscheduled study clinic visit |
| Secondary | Perception of intervention | Month 6 | The median scores of the first 4 Likert-scale questions on the interview (e.g. Overall Experience). Higher scores indicate a more positive perception. |
1 to 10 of 35Source ClinicalTrials.gov
See all 35 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07903324
GET https://conductscience.org/api/trials/v1/NCT07903324/registered?page=2